Electromagnetic interference on cardiac pacemakers and implantable cardioverter defibrillators during endoscopy as reported to the US Federal Drug Administration.

MLA

Samuels, Jason M., et al. “Electromagnetic Interference on Cardiac Pacemakers and Implantable Cardioverter Defibrillators during Endoscopy as Reported to the US Federal Drug Administration.” Surgical Endoscopy, vol. 35, no. 7, July 2021, pp. 3796–801. EBSCOhost, https://doi.org/10.1007/s00464-020-07872-2.

APA

Samuels, J. M., Overbey, D. M., Wikiel, K. J., Jones, T. S., Robinson, T. N., & Jones, E. L. (2021). Electromagnetic interference on cardiac pacemakers and implantable cardioverter defibrillators during endoscopy as reported to the US Federal Drug Administration. Surgical Endoscopy, 35(7), 3796–3801. https://doi.org/10.1007/s00464-020-07872-2

Chicago

Samuels, Jason M, Douglas M Overbey, Krzysztof J Wikiel, Teresa S Jones, Thomas N Robinson, and Edward L Jones. 2021. “Electromagnetic Interference on Cardiac Pacemakers and Implantable Cardioverter Defibrillators during Endoscopy as Reported to the US Federal Drug Administration.” Surgical Endoscopy 35 (7): 3796–3801. doi:10.1007/s00464-020-07872-2.